Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

ZenCharts Inks 3-Year Contract With Solutions Recovery Center

cornichon healthcare

ZenCharts, a division of Sanomedics, Inc. (OTC: SIMH), announced that it secured an exclusive three-year contract to provide Electronic Health Records (“EHR”) software to Solutions Recovery Center, an operator of Addiction Treatment Services in the South Florida region.

“After reviewing the competitive landscape, we selected ZenCharts because of the numerous product features that the ZenCharts’ solution offers. These features include an easy to use interface, HIPPA compliance and automated alerts,” said Dan Callahan CEO of Solutions Recovery Center. In addition, Mr. Callahan stated, “As Addiction Recovery Services enters a period of rapid growth, key components of a profitable and successful patient care center include faster reimbursement times and cost containment. We believe ZenCharts is on the cutting edge of providing a long-term software solution that satisfies both these requirements.”

Keith Houlihan CEO of ZenCharts and President of Sanomedics commented, “Our recent strategic investment in ZenCharts is already adding value to our organization.” Furthermore, he added, “Industry experts like Mr. Callahan and his team at Solutions Recovery Center have recognized the value our software solution brings to the table. We expect more operators to adopt our solution in the near future.”

Financial terms of the deal were not disclosed.

About Sanomedics, Inc.
Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge healthcare technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.  In May 2015, Sanomedics acquired ZenCharts.  ZenCharts is a leading provider of Electronic Health Records (“EHR”) software solutions aimed at healthcare service providers.  ZenCharts’ software helps healthcare service providers reduce errors, increase patient customization, and automate record keeping.  ZenCharts’ customers enjoy lower error rates, faster reimbursement times and cost containment.

Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “predicts,” “potential,” or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.

Investor Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
pcarlson@kcsa.com / ebarker@kcsa.com

Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273
cfont@kcsa.com / aherweg@kcsa.com

Source